Oncology Imaging Guidelines

This Oncology Imaging Policy defines indications and utilization criteria for advanced imaging (CT, MRI, PET, MUGA, echocardiography, etc.) for diagnosis, staging, surveillance, and treatment monitoring across a broad range of malignancies in adults, adolescents/young adults and pediatric patients (e.g., CNS, head & neck, lung, breast, GI, sarcoma, neuroendocrine, renal cell, thyroid). Imaging is subject to age-at-diagnosis and diagnosis‑specific guideline selection, generally requires a recent clinical evaluation (within 60 days) or physician review for atypical presentations, limits routine/asymptomatic screening and PET surveillance, permits initial staging imaging once when standard therapy is planned, prefers MRI over CT when feasible and echocardiography for cardiac function assessment, and excludes advanced imaging for individuals declining standard oncologic therapy; modality- and frequency-specific restrictions also apply.

"ONC-23: Cervical Cancer"